Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bonneau

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
The Veterinary Record|February 7, 2001
Identification of seven serotypes of bluetongue virus from the People's Republic of ChinaN Zhang, N J MacLachlan, K R Bonneau, et al.
Journal of Virology|March 16, 2007
Unique thermodynamic response of tipranavir to human immunodeficiency virus type 1 protease drug resistance mutationsS Muzammil, A A Armstrong, L W Kang, et al.
The Journal of Biological Chemistry|March 5, 1993
Functional expression of human cathepsin S in Saccharomyces cerevisiae. Purification and characterization of the recombinant enzymeD Brömme, P R Bonneau, P Lachance, et al.
Nature|September 24, 2013
Nanog, Pou5f1 and SoxB1 activate zygotic gene expression during the maternal-to-zygotic transitionMiler T Lee, Ashley R Bonneau, Carter M Takacs, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|January 1, 1997
Improved purification protocol of the HSV-1 protease catalytic domain, using immunoaffinityG McKercher, P R Bonneau, L Lagacé, et al.
Angewandte Chemie (International Ed. in English)|May 2, 2018
The Conformation of a Peptidyl Methyl Ketone Inhibitor Bound to the Human Cytomegalovirus ProteaseSteven R LaPlante, Dale R Cameron, Norman Aubry, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2000
NMR line-broadening and transferred NOESY as a medicinal chemistry tool for studying inhibitors of the hepatitis C virus NS3 protease domainS R LaPlante, N Aubry, P R Bonneau, et al.
Biochemistry|November 5, 1997
Evidence of a conformational change in the human cytomegalovirus protease upon binding of peptidyl-activated carbonyl inhibitorsP R Bonneau, C Grand-Maître, D J Greenwood, et al.
Bioorganic & Medicinal Chemistry Letters|April 25, 2007
Scaffold hopping in the rational design of novel HIV-1 non-nucleoside reverse transcriptase inhibitorsJeff A O'Meara, Araz Jakalian, Steven LaPlante, et al.
Molecular Cell|February 19, 2022
The landscape of pioneer factor activity reveals the mechanisms of chromatin reprogramming and genome activationLiyun Miao, Yin Tang, Ashley R Bonneau, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
The Veterinary Record|February 7, 2001
Identification of seven serotypes of bluetongue virus from the People's Republic of ChinaN Zhang, N J MacLachlan, K R Bonneau, et al.
Journal of Virology|March 16, 2007
Unique thermodynamic response of tipranavir to human immunodeficiency virus type 1 protease drug resistance mutationsS Muzammil, A A Armstrong, L W Kang, et al.
The Journal of Biological Chemistry|March 5, 1993
Functional expression of human cathepsin S in Saccharomyces cerevisiae. Purification and characterization of the recombinant enzymeD Brömme, P R Bonneau, P Lachance, et al.
Nature|September 24, 2013
Nanog, Pou5f1 and SoxB1 activate zygotic gene expression during the maternal-to-zygotic transitionMiler T Lee, Ashley R Bonneau, Carter M Takacs, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|January 1, 1997
Improved purification protocol of the HSV-1 protease catalytic domain, using immunoaffinityG McKercher, P R Bonneau, L Lagacé, et al.
Angewandte Chemie (International Ed. in English)|May 2, 2018
The Conformation of a Peptidyl Methyl Ketone Inhibitor Bound to the Human Cytomegalovirus ProteaseSteven R LaPlante, Dale R Cameron, Norman Aubry, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2000
NMR line-broadening and transferred NOESY as a medicinal chemistry tool for studying inhibitors of the hepatitis C virus NS3 protease domainS R LaPlante, N Aubry, P R Bonneau, et al.
Biochemistry|November 5, 1997
Evidence of a conformational change in the human cytomegalovirus protease upon binding of peptidyl-activated carbonyl inhibitorsP R Bonneau, C Grand-Maître, D J Greenwood, et al.
Bioorganic & Medicinal Chemistry Letters|April 25, 2007
Scaffold hopping in the rational design of novel HIV-1 non-nucleoside reverse transcriptase inhibitorsJeff A O'Meara, Araz Jakalian, Steven LaPlante, et al.
Molecular Cell|February 19, 2022
The landscape of pioneer factor activity reveals the mechanisms of chromatin reprogramming and genome activationLiyun Miao, Yin Tang, Ashley R Bonneau, et al.
Pageof 6